Financial Data and Key Metrics Changes - In Q2 2025, the company generated revenue of $7,500,000, an increase from $6,000,000 in Q1 2025, bringing year-to-date revenue to $13,500,000 [10] - Operating expenses for Q2 were $33,400,000, up by $3,400,000 compared to $30,000,000 in Q1 2025, primarily due to costs associated with factory acceptance testing [10] - Year-to-date operating loss was $49,900,000, with a net loss of $40,500,000 or $0.22 per share [10] - Capital expenditures totaled $5,000,000, mainly for the construction of the continuous electrolyte production pilot line [10] - Total liquidity at the end of Q2 was $279,800,000 [11] Business Line Data and Key Metrics Changes - The revenue recognized in Q2 was driven by the achievement of the factory acceptance testing milestone under the line installation agreement with SK On [10] - The company is progressing on its electrolyte development roadmap, having completed ordering long lead equipment and begun detailed design for a continuous manufacturing pilot line for sulfide electrolyte production [7] Market Data and Key Metrics Changes - The company has engaged in active sampling of its electrolyte with key strategic customers, indicating ongoing demand for multiple generations of its electrolyte [8] Company Strategy and Development Direction - The company aims to drive electrolyte innovation and performance through feedback from cell development and customers, as highlighted by its partnership with BMW [5] - The collaboration with SK On is focused on developing solid-state cells based on the company's technology and operating a solid-state pilot line [6] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential to deliver strong returns for shareholders and acknowledged the commitment and support from employees, partners, and stakeholders [13] Other Important Information - The company repurchased 3,300,000 shares during Q2 at an average price of $1.05, totaling approximately $3,600,000 under its stock repurchase program [11] Q&A Session Summary - The Q&A session was briefly mentioned, but no specific questions or answers were provided in the transcript [14][15]